Chinese Center for Disease Control and Prevention, Beijing, China.
Weifang Medical University, Weifang, China.
Lancet. 2020 Jul 4;396(10243):63-70. doi: 10.1016/S0140-6736(20)31278-2. Epub 2020 Jun 4.
COVID-19 was declared a pandemic by WHO on March 11, 2020, the first non-influenza pandemic, affecting more than 200 countries and areas, with more than 5·9 million cases by May 31, 2020. Countries have developed strategies to deal with the COVID-19 pandemic that fit their epidemiological situations, capacities, and values. We describe China's strategies for prevention and control of COVID-19 (containment and suppression) and their application, from the perspective of the COVID-19 experience to date in China. Although China has contained severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and nearly stopped indigenous transmission, a strong suppression effort must continue to prevent re-establishment of community transmission from importation-related cases. We believe that case finding and management, with identification and quarantine of close contacts, are vitally important containment measures and are essential in China's pathway forward. We describe the next steps planned in China that follow the containment effort. We believe that sharing countries' experiences will help the global community manage the COVID-19 pandemic by identifying what works in the struggle against SARS-CoV-2.
世界卫生组织于 2020 年 3 月 11 日宣布 COVID-19 为大流行,这是第一次非流感大流行,影响了 200 多个国家和地区,截至 2020 年 5 月 31 日,已有超过 590 万例病例。各国根据各自的流行病学情况、能力和价值观制定了应对 COVID-19 大流行的策略。我们从中国迄今为止的 COVID-19 经验的角度描述了中国防控 COVID-19(遏制和抑制)的策略及其应用。尽管中国已经遏制了严重急性呼吸综合征冠状病毒 2(SARS-CoV-2),并几乎停止了本土传播,但必须继续进行强有力的抑制努力,以防止因输入性病例而重新建立社区传播。我们认为,病例发现和管理,包括密切接触者的识别和隔离,是至关重要的遏制措施,是中国前进道路上必不可少的。我们描述了中国在遏制努力之后计划采取的下一步措施。我们相信,分享各国的经验将有助于全球社会通过确定对抗 SARS-CoV-2 的有效措施来管理 COVID-19 大流行。
Lancet. 2020-4-25
JAMA Netw Open. 2020-6-1
Front Cell Infect Microbiol. 2025-6-20
Front Cell Infect Microbiol. 2025-6-9
China CDC Wkly. 2020-1-24
China CDC Wkly. 2020-5-8
China CDC Wkly. 2020-5-8
China CDC Wkly. 2020-5-8
J Travel Med. 2020-12-23
Zhonghua Liu Xing Bing Xue Za Zhi. 2020-5-10
Science. 2020-5-29
Nat Rev Immunol. 2020-4-28